Geode Capital Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Geode Capital Management’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,600,356	Closed	-$67.4M	–	4812
2023 Q2	$67.4M	Buy	1,600,356 +68,407	+4%	+$2.77M	0.01%	1034
2023 Q1	$54.6M	Buy	1,531,949 +61,825	+4%	+$2.24M	0.01%	1127
2022 Q4	$53.9M	Buy	1,470,124 +66,953	+5%	+$2.65M	0.01%	1096
2022 Q3	$66.2M	Buy	1,403,171 +7,439	+0.5%	+$480K	0.01%	907
2022 Q2	$100M	Sell	1,395,732 -20,872	-1%	-$1.53M	0.01%	682
2022 Q1	$115M	Buy	1,416,604 +51,667	+4%	+$4.37M	0.01%	708
2021 Q4	$140M	Buy	1,364,937 +14,724	+1%	+$1.41M	0.02%	667
2021 Q3	$118M	Buy	1,350,213 +45,275	+3%	+$4.1M	0.02%	704
2021 Q2	$117M	Buy	1,304,938 +247,121	+23%	+$20.9M	0.02%	713
2021 Q1	$80.2M	Buy	1,057,817 +108,162	+11%	+$8.15M	0.01%	889
2020 Q4	$64.7M	Buy	949,655 +112,651	+13%	+$7.02M	0.01%	931
2020 Q3	$44.5M	Buy	837,004 +31,216	+4%	+$1.86M	0.01%	985
2020 Q2	$46.9M	Sell	805,788 -167,958	-17%	-$9.03M	0.01%	928
2020 Q1	$38.4M	Buy	973,746 +60,585	+7%	+$3.54M	0.01%	907
2019 Q4	$54.3M	Buy	913,161 +23,622	+3%	+$1.27M	0.01%	889
2019 Q3	$47.3M	Buy	889,539 +30,480	+4%	+$1.56M	0.01%	914
2019 Q2	$43.9M	Sell	859,059 -5,510	-0.6%	-$257K	0.01%	944
2019 Q1	$44.7M	Buy	864,569 +126,002	+17%	+$6.11M	0.01%	896
2018 Q4	$29.1M	Buy	738,567 +50,175	+7%	+$2.33M	0.01%	1026
2018 Q3	$35.5M	Buy	688,392 +87,405	+15%	+$4.28M	0.01%	1015
2018 Q2	$28.2M	Buy	600,987 +47,894	+9%	+$1.98M	0.01%	1106
2018 Q1	$19.6M	Sell	553,093 -528,115	-49%	-$20.7M	0.01%	1276
2017 Q4	$47.1M	Buy	1,081,208 +517,633	+92%	+$24.2M	0.02%	732
2017 Q3	$29.5M	Buy	563,575 +58,745	+12%	+$3.28M	0.01%	964
2017 Q2	$29.5M	Buy	504,830 +47,628	+10%	+$2.47M	0.01%	929
2017 Q1	$21M	Buy	457,202 +21,171	+5%	+$1.05M	0.01%	1110
2016 Q4	$22.9M	Sell	436,031 -8,469	-2%	-$410K	0.01%	989
2016 Q3	$19.8M	Buy	444,500 +53,881	+14%	+$2.34M	0.01%	1006
2016 Q2	$14.9M	Buy	390,619 +109,007	+39%	+$4.79M	0.01%	1143
2016 Q1	$11.6K	Buy	281,612 +39,501	+16%	+$1.63M	0.01%	1293
2015 Q4	$11.7M	Buy	242,111 +50,152	+26%	+$2.23M	0.01%	1254
2015 Q3	$7.68M	Buy	191,959 +70,581	+58%	+$3.08M	﹤0.01%	1537
2015 Q2	$4.87M	Buy	121,378 +55,365	+84%	+$1.91M	﹤0.01%	1909
2015 Q1	$2.16M	Buy	66,013 +12,323	+23%	+$340K	﹤0.01%	2391
2014 Q4	$1.38M	Buy	+53,690	New	+$1.28M	﹤0.01%	2647

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

CFB

Cullen/Frost Bankers San Antonio, Texas $8.81B AUM 22.47% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Geode Capital Management's SYNH Position: Q3 2023 in Review

Geode Capital Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 1,600,356 shares — an estimated $67.4M sold.

Geode Capital Management first reported a position in SYNH in Q4 2014 and held it in 35 quarters. The position peaked at $140M in Q4 2021. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

Geode Capital Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Geode Capital Management sold 1,600,356 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $67.4M.
Geode Capital Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2014 and held it in 35 quarters.
Geode Capital Management's Syneos Health, Inc. Class A Common Stock position peaked at $140M in Q4 2021.
10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Geode Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.